{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:04:16Z","timestamp":1793329456757,"version":"4.5.0"},"reference-count":91,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"DOI":"10.14797\/mdcvj.1607","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:46:27Z","timestamp":1755002787000},"page":"37-53","source":"Crossref","is-referenced-by-count":8,"title":["Drug-Coated Balloons for Coronary Interventions: A Focused Review"],"prefix":"10.14797","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2268-1391","authenticated-orcid":false,"given":"Akash H.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3584-9825","authenticated-orcid":false,"given":"Mark W.","family":"Abdelnour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6645-6367","authenticated-orcid":false,"given":"Antonio H.","family":"Frangieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"key":"key20250812124619_B1","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/BF01875120","article-title":"Die sondierung des rechten herzens","volume":"8","year":"1929","journal-title":"Klinische Wochenschrift"},{"issue":"1","key":"key20250812124619_B2","article-title":"Balloon Angioplasty - The Legacy of Andreas Gr\u00fcntzig, M.D. (1939-1985)","volume":"29","year":"2014","journal-title":"Front Cardiovasc Med"},{"key":"key20250812124619_B3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/01.CIR.30.5.654","article-title":"Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application","volume":"30","year":"1964","journal-title":"Circulation"},{"issue":"8","key":"key20250812124619_B4","first-page":"1311","article-title":"[Self-expanding coronary endoprosthesis in the prevention of restenosis following transluminal angioplasty. Preliminary clinical study]","volume":"80","year":"1987","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"2","key":"key20250812124619_B5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/CIRCINTERVENTIONS.110.960872","article-title":"Stent: The Man and Word Behind the Coronary Metal Prosthesis","volume":"4","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"13","key":"key20250812124619_B6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"key20250812124619_B7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention","volume":"75","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20250812124619_B8","article-title":"The EBC TWO Study (European Bifurcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True Bifurcations","volume":"9","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"key20250812124619_B9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2016.02.020","article-title":"Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial","volume":"176","year":"2016","journal-title":"Am Heart J"},{"issue":"2","key":"key20250812124619_B10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","year":"1997","journal-title":"Circulation"},{"issue":"7","key":"key20250812124619_B11","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0735-1097(00)00614-8","article-title":"Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo","volume":"35","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key20250812124619_B12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.rli.0000116125.96544.64","article-title":"Inhibition of restenosis in stented porcine coronary arteries: uptake of Paclitaxel from angiographic contrast media","volume":"39","year":"2004","journal-title":"Invest Radiol"},{"issue":"15","key":"key20250812124619_B13","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0195-668X(03)00317-8","article-title":"Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model","volume":"24","year":"2003","journal-title":"Eur Heart J"},{"issue":"8","key":"key20250812124619_B14","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0735-1097(03)01056-8","article-title":"Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation","volume":"42","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key20250812124619_B15","article-title":"Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications","volume":"2","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"3","key":"key20250812124619_B16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty","volume":"104","year":"2015","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"key20250812124619_B17","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1172\/JCI119038","article-title":"Rapamycin inhibits vascular smooth muscle cell migration","volume":"98","year":"1996","journal-title":"J Clin Invest"},{"issue":"3 Suppl","key":"key20250812124619_B18","first-page":"7S","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","year":"2003","journal-title":"Transplant Proc"},{"issue":"6","key":"key20250812124619_B19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","article-title":"Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon","volume":"12","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"key20250812124619_B20","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.110.936922","article-title":"Drug-coated balloons for the prevention of vascular restenosis","volume":"121","year":"2010","journal-title":"Circulation"},{"key":"key20250812124619_B21","unstructured":"StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; c2025. Omeh, DJ, Shlofmitz, E. Restenosis of Stented Coronary Arteries; 2025 Jan [cited 2025 Jun 9]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31424723"},{"issue":"4","key":"key20250812124619_B22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1253\/circj.CJ-16-1069","article-title":"Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation - An Optical Coherence Tomography Study","volume":"81","year":"2017","journal-title":"Circ J"},{"issue":"13","key":"key20250812124619_B23","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2020.08.002","article-title":"Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States","volume":"76","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key20250812124619_B24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","article-title":"Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"5","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"key20250812124619_B25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial","volume":"331","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"key20250812124619_B26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4244\/EIJY14M08_12","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study","volume":"11","year":"2015","journal-title":"EuroIntervention"},{"issue":"12","key":"key20250812124619_B27","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jcin.2016.03.037","article-title":"Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial","volume":"9","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"key20250812124619_B28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4244\/EIJV10I4A77","article-title":"Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial","volume":"10","year":"2014","journal-title":"EuroIntervention"},{"issue":"4","key":"key20250812124619_B29","article-title":"Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study","volume":"9","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"15","key":"key20250812124619_B30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","volume":"59","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20250812124619_B31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcin.2013.08.011","article-title":"A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial","volume":"7","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"9865","key":"key20250812124619_B32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","volume":"381","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"key20250812124619_B33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial","volume":"66","year":"2015","journal-title":"JACC"},{"key":"key20250812124619_B34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2017.11.008","article-title":"Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: A randomized RESTORE trial","volume":"197","year":"2018","journal-title":"Am Heart J"},{"issue":"10","key":"key20250812124619_B35","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4244\/EIJ-D-17-01079","article-title":"Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial","volume":"14","year":"2018","journal-title":"EuroIntervention"},{"issue":"3","key":"key20250812124619_B36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial","volume":"11","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"key20250812124619_B37","volume-title":"Presented at: CRT 2025","year":"2025"},{"issue":"15","key":"key20250812124619_B38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/eurheartj\/ehad026","article-title":"Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial","volume":"44","year":"2023","journal-title":"Eur Heart J"},{"issue":"23","key":"key20250812124619_B39","article-title":"Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis Study","volume":"13","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"38","key":"key20250812124619_B40","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1093\/eurheartj\/ehz594","article-title":"Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)","volume":"41","year":"2020","journal-title":"Eur Heart J"},{"issue":"36","key":"key20250812124619_B41","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","year":"2024","journal-title":"Eur Heart J"},{"issue":"5","key":"key20250812124619_B42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/joic.12327","article-title":"Comparison of Clinical Results Following the Use of Drug-Eluting Balloons for a Bare-Metal Stent and Drug-Eluting Stent Instent Restenosis","volume":"29","year":"2016","journal-title":"J Interv Cardiol"},{"issue":"4","key":"key20250812124619_B43","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.4244\/EIJ-D-19-00051","article-title":"A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis","volume":"16","year":"2020","journal-title":"EuroIntervention"},{"issue":"13","key":"key20250812124619_B44","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2017.04.024","article-title":"Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial","volume":"10","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"key20250812124619_B45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jjcc.2019.04.011","article-title":"Effect of combination of non-slip element balloon and drug-coating balloon for in-stent restenosis lesions (ELEGANT study)","volume":"74","year":"2019","journal-title":"J Cardiol"},{"issue":"4","key":"key20250812124619_B46","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.4244\/EIJ-D-18-01191","article-title":"In-stent restenosis characteristics and repeat stenting underexpansion: insights from optical coherence tomography","volume":"16","year":"2020","journal-title":"EuroIntervention"},{"issue":"22","key":"key20250812124619_B47","article-title":"Intravascular Imaging for Guiding In-Stent Restenosis and Stent Thrombosis Therapy","volume":"11","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"key20250812124619_B48","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.4244\/EIJ-D-21-01034","article-title":"Management of in-stent restenosis","volume":"18","year":"2022","journal-title":"EuroIntervention"},{"issue":"10194","key":"key20250812124619_B49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"17","key":"key20250812124619_B50","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial","volume":"15","year":"2020","journal-title":"EuroIntervention"},{"key":"key20250812124619_B51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00392-018-1346-8","article-title":"Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute","volume":"108","year":"2019","journal-title":"Clinical Research in Cardiology"},{"issue":"3","key":"key20250812124619_B52","first-page":"234","article-title":"Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study","volume":"108","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"key20250812124619_B53","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00392-022-02106-y","article-title":"Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice","volume":"112","year":"2023","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"key20250812124619_B54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jcin.2023.01.380","article-title":"Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI","volume":"16","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"key20250812124619_B55","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial","volume":"12","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"key20250812124619_B56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.carrev.2009.04.007","article-title":"Percutaneous coronary intervention for small vessel coronary artery disease","volume":"11","year":"2010","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"key20250812124619_B57","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4244\/EIJV9I5A99","article-title":"Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?","volume":"9","year":"2013","journal-title":"EuroIntervention"},{"issue":"16","key":"key20250812124619_B58","first-page":"1291","article-title":"Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial","volume":"96","year":"2010","journal-title":"The PICCOLETO study. Heart"},{"issue":"24","key":"key20250812124619_B59","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"key20250812124619_B60","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jcin.2015.04.008","article-title":"3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO)","volume":"8","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"key20250812124619_B61","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial","volume":"11","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"key20250812124619_B62","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jcin.2019.10.062","article-title":"Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR Report","volume":"13","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"16","key":"key20250812124619_B63","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.jcin.2021.06.025","article-title":"Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial","volume":"14","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"key20250812124619_B64","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial","volume":"13","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"10150","key":"key20250812124619_B65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"key20250812124619_B66","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4244\/EIJV9I5A99","article-title":"Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?","volume":"9","year":"2013","journal-title":"EuroIntervention"},{"issue":"11","key":"key20250812124619_B67","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jcin.2014.04.026","article-title":"Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts)","volume":"7","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"key20250812124619_B68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12928-023-00921-2","article-title":"Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics","volume":"38","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"issue":"5","key":"key20250812124619_B69","first-page":"629","article-title":"Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry","volume":"71","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7 Suppl K","key":"key20250812124619_B70","first-page":"K61","article-title":"Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial","year":"2011","journal-title":"EuroIntervention"},{"issue":"7","key":"key20250812124619_B71","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00392-015-0957-6","article-title":"Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial","volume":"105","year":"2016","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"key20250812124619_B72","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carrev.2015.07.009","article-title":"Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study","volume":"16","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"issue":"Suppl C","key":"key20250812124619_B73","first-page":"C79","article-title":"Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study","volume":"25","year":"2023","journal-title":"Eur Heart J Suppl"},{"issue":"4","key":"key20250812124619_B74","first-page":"346","article-title":"The role of drug-coated balloons for coronary bifurcation management: results from the prospective EASTBOURNE-BIF study","volume":"72","year":"2024","journal-title":"Minerva Cardiol Angiol"},{"issue":"1","key":"key20250812124619_B75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4244\/EIJV10I1A10","article-title":"A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results","volume":"10","year":"2014","journal-title":"EuroIntervention"},{"issue":"7","key":"key20250812124619_B76","first-page":"1138","article-title":"A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial","volume":"80","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"key20250812124619_B77","article-title":"Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery","volume":"16","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"key20250812124619_B78","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jcin.2013.07.005","article-title":"The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease","volume":"6","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"key20250812124619_B79","first-page":"163","article-title":"Procedural and one-year outcomes following drug-eluting stent and drug-coated balloon combination for the treatment of de novo diffuse coronary artery disease: the HYPER Study","volume":"72","year":"2024","journal-title":"Minerva Cardiol Angiol"},{"issue":"9","key":"key20250812124619_B80","article-title":"Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions","volume":"23","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"key20250812124619_B81","first-page":"E39","article-title":"Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction","volume":"34","year":"2022","journal-title":"J Invasive Cardiol"},{"issue":"4","key":"key20250812124619_B82","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12928-020-00713-y","article-title":"Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction","volume":"36","year":"2021","journal-title":"Cardiovasc Interv Ther"},{"issue":"3","key":"key20250812124619_B83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"key20250812124619_B84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","year":"2019","journal-title":"Eur Heart J"},{"issue":"2","key":"key20250812124619_B85","first-page":"181","article-title":"Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry","volume":"93","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"key20250812124619_B86","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group","volume":"13","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"key20250812124619_B87","article-title":"Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review","volume":"18","year":"2023","journal-title":"Interv Cardiol"},{"key":"key20250812124619_B88","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjcard.2023.08.113","article-title":"Prognostic Impact of Drug-Coated Balloons in Patients With Diabetes Mellitus: A Propensity-Matched Study","volume":"206","year":"2023","journal-title":"Am J Cardiol"},{"key":"key20250812124619_B89","article-title":"The comparative short-term efficacy and safety of drug-coated balloon vs","volume":"10","year":"2022","journal-title":"drug-eluting stent for treating small-vessel coronary artery lesions in diabetic patients. Front Public Health"},{"issue":"7","key":"key20250812124619_B90","first-page":"1423","article-title":"Drug-coated balloons in high-risk patients and diabetes mellitus: A meta-analysis of 10 studies","volume":"104","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"key":"key20250812124619_B91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ahj.2019.03.011","article-title":"Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation-Individual patient data pooled analysis from 6 randomized controlled trials","volume":"213","year":"2019","journal-title":"Am Heart J"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:46:36Z","timestamp":1755002796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1607\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8,12]]}},"alternative-id":["10.14797\/mdcvj.1607"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1607","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}